Clinical Features, STAT3 Gene Mutations and Th17 Cell Analysis in Nine Children with Hyper-IgE Syndrome in Mainland China

Scandinavian Journal of Immunology

Volumn 78, Issue 3, 2013, Pages 258-265

  Zhang, L Y ^a   Tian, W ^a   Shu, L ^a   Jiang, L P ^a   Zhan, Y Z ^a   Liu, W ^a   Zhao, X D ^a   Cui, Y X ^b   Tang, X M ^a   Wang, M ^a   Wu, D Q ^a   Yang, X Q ^a  

^a CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b GUIZHOU PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN; INTERLEUKIN 17; STAT3 PROTEIN;

ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; CHINA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; HYPER IGE SYNDROME; LUNG ABSCESS; LUNG LOBECTOMY; MALE; MISSENSE MUTATION; PNEUMATOCELE; PNEUMOTHORAX; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN ABSCESS; TH17 CELL; WILD TYPE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; IMMUNOGLOBULIN E; INFANT; JOB'S SYNDROME; LYMPHOCYTE COUNT; MALE; STAPHYLOCOCCAL INFECTIONS; STAT3 TRANSCRIPTION FACTOR; TH17 CELLS;

EID: 84882945022     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12063     Document Type: Article

References (35)

1. Grimbacher B, Holland SM, Gallin JI et al. Hyper-IgE syndrome with recurrent infections-an autosomal dominant multisystemic disorder. N Engl J Med 1999;340:692-702.
2. Ochs HD, Smith CIE, Puck JM. Primary Immunodeficiency Diseases: A Molecular and Genetic Approach, 2nd edn. New York: Oxford University Press, 2007:496-504.
3. Grimbacher B, Schäffer AA, Holland SM et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet 1999;65:735-44.
4. Holland SM, DeLeo FR, Elloumi HZ et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007;357:1608-19.
5. Milner JD, Brenchley JM, Laurence A et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008;452:773-6.
6. Tang IMS, Lee TL, Chan KW et al. Signal transducer and activator of transcription 3 (STAT3) gene mutations in two patients with Hyperimmunoglobulin E syndrome. HK J Paediatr (New Series) 2009;14:4-10.
7. Lee WI, Huang JL, Lin SJ et al. Clinical, immunological and genetic features in Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES). Immunobiology 2011;216:909-17.
8. Xie L, Hu X, Li Y, Zhang W, Chen L. Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China. Clin Dev Immunol 2010; 2010: 289873.
9. Liu JY, Li Q, Chen TT, Guo X, Ge J, Yuan LX. Destructive pulmonary staphylococcal infection in a boy with hyper-IgE syndrome: a novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene (p.Y657S). Eur J Pediatr 2011;170:661-6.
10. Chamlin SL, McCalmont TH, Cunningham BB et al. Cutaneous manifestations of hyper-IgE syndrome in infants and children. J Pediatr 2002;141:572-5.
11. Erlewyn-Lajeunesse MD. Hyperimmunoglobulin-E syndrome with recurrent infection: a review of current opinion and treatment. Pediatr Allergy Immunol 2000;11:133-41.
12. Renner ED, Rylaarsdam S, Anover-Sombke S et al. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol 2008;122:181-7.
13. Woellner C, Gertz EM, Schäffer AA et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol 2010;125:424-32.
14. Schimke LF, Sawalle-Belohradsky J, Roesler J et al. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J Allergy Clin Immunol 2010;126:611-7.
15. Chandesris MO, Melki I, Natividad A et al. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine (Baltimore) 2012;91:e1-19.
16. Heimall J, Davis J, Shaw PA et al. Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES). Clin Immunol 2011;139:75-84.
17. Zhang Q, Davis JC, Lamborn IT et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med 2009;361:2046-55.
18. Engelhardt KR, McGhee S, Winkler S et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol 2009;124:1289-302. e4.
19. Zhong Z, Wen Z, Darnell JE Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994;264:95-8.
20. Minegishi Y, Saito M, Tsuchiya S et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007;448:1058-62.
21. Kida H, Mucenski ML, Thitoff AR et al. GP130-STAT3 regulates epithelial cell migration and is required for repair of the bronchiolar epithelium. Am J Pathol 2008;172:1542-54.
22. Minegishi Y, Saito M, Nagasawa M et al. Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J Exp Med 2009; 206: 1291-301.
23. Sekhsaria V, Dodd LE, Hsu AP et al. Plasma metalloproteinase levels are dysregulated in signal transducer and activator of transcription 3 mutated hyper-IgE syndrome. J Allergy Clin Immunol 2011;128:1124-7.
24. Siegel AM, Heimall J, Freeman AF et al. A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity 2011;35:806-18.
25. Avery DT, Deenick EK, Ma CS et al. B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J Exp Med 2011;207:155-71.
26. Speckmann C, Enders A, Woellner C et al. Reduced memory B cells in patients with hyper IgE syndrome. Clin Immunol 2008;129: 448-54.
27. Meyer-Bahlburg A, Renner ED, Rylaarsdam S et al. Heterozygous signal transducer and activator of transcription 3 mutations in hyper-IgE syndrome result in altered B-cell maturation. J Allergy Clin Immunol 2012;129:559-62, 562, e1-e2.
28. Wesemann DR, Magee JM, Boboila C et al. Immature B cells preferentially switch to IgE with increased direct Sμ to Sε recombination. J Exp Med 2011;208:2733-46.
29. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005;6:1123-32.
30. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008;28:454-67.
31. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007;8:942-9.
32. Acosta-Rodriguez EV, Rivino L, Geginat J et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007;8:639-46.
33. Ma CS, Chew GY, Simpson N et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 2008;205: 1551-7.
34. Puel A, Cypowyj S, Bustamante J et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 2011;332:65-8.
35. Zhang Q, Su HC. Hyperimmunoglobulin E syndromes in pediatrics: hyperimmunoglobulin E syndromes in pediatrics. Curr Opin Pediatr 2011;23:653-8.